Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) over five years because of the United States' demand for sensitive information.
This move was revealed after a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesman has since explained that the United States was requesting genetic material for research and profit while refused to share the benefits from future vaccines.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to reach a deal agreeable to all parties so the nation's critical HIV programme can be sustained.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US following concerns were filed about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.
Based on reports, Sixteen nations in Africa have so far agreed to these new agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent guarantee of access to any medical innovations – like new medicines or tests – that could be developed from that shared data," he stated.
"Effectively, our country would provide the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were undermining structures already established via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This mechanism is intended to guarantee that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome further dialogue with our American counterparts on how future collaboration might be designed in a manner that honours the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks must proceed given that a large portion of the country's Aids initiatives were funded by foreign aid.
"If technical issues exist, including those relating to information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group added.
This impasse highlights the continuing tensions between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.